The global blood screening market was valued at USD 2.31 billion in 2018 and is anticipated to grow to USD 6.63 billion by 2032, reflecting a compound annual growth rate (CAGR) of 7.9% over the forecast period. In 2018, North America led the global market, accounting for 41.86% of the total share.

The blood screening market plays a crucial role in ensuring the safety and quality of blood used for transfusions, organ transplants, and clinical testing. This market is driven by the growing prevalence of infectious diseases, the rising demand for early disease detection, and the increasing emphasis on public health safety. Advancements in diagnostic technologies, such as nucleic acid testing and immunoassays, have enhanced the accuracy, speed, and efficiency of blood screening procedures. The blood screening market spans various applications including infectious disease detection, cancer biomarkers, and genetic disorder testing. As healthcare systems worldwide continue to strengthen their disease prevention and control strategies, the blood screening market is expected to experience sustained growth, especially in emerging economies with expanding diagnostic infrastructures.

Continue reading for more details: https://www.fortunebusinessinsights.com/blood-screening-market-102552

Market Segmentation

• In terms of product type, the Blood Screening Market includes assay kits, testing instruments, and software solutions.
• By technique, the Blood Screening Market is segmented into ELISA, nucleic acid testing, immunoassays, and point-of-care testing.
• Application-wise, the Blood Screening Market covers infectious diseases, cancer markers, genetic screening, and transfusion-transmitted infections.
• Based on end-user, the Blood Screening Market serves hospitals, diagnostic laboratories, blood banks, and research institutes.
• The Blood Screening Market is also segmented by technology adoption, ranging from conventional manual systems to fully automated high-throughput platforms.

List Of Key Companies Profiled:

• Bio-Rad Laboratories, Inc.
• Grifols, S.A.
• Hoffmann-La Roche
• Ortho Clinical Diagnostics
• BD
• DiaSorin S.p.A.
• Thermo Fisher Scientific Inc.
• Abbott
• QUOTIENT